Floatz logo

Zoledronate

Fractures, Bone

GlaxoSmithKlineSmall moleculePhase 3Dormant
B
63/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
48/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Fractures, Bone cohort.

Asset / SponsorPhaseRating
RISEDRONIC ACID
Boston VA Research Institute, Inc.
Phase 4BB
Calcium
Boston VA Research Institute, Inc.
Phase 4BB
VITAMIN D
Boston VA Research Institute, Inc.
Phase 4BB
SUFENTANYL
West Virginia University
Phase 4BB
Gtx-006
GTx
Phase 3BB

View all 10 →

Same molecule, other indications

Zoledronate is also rated in:

metastatic carcinoma in the boneDormant
BBB
Indicative ·
79 / 100
View asset →
osteoporosisDormant
BBB
Indicative ·
76 / 100
View asset →
breast carcinomaDormant
BBB
Indicative ·
75 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →